Impact of body weight-based dosing of palonosetron and ondansetron on postoperative nausea and vomiting following laparoscopic sleeve gastrectomy: a randomized, double-blind study.

Büşra Burcu Nadir Adnan Hacim Ozan Çalişkan Serdar Demirgan Talar Vartanoglu Aktokmakyan Serhat Meric Tomris Duymaz Onder Karabay Ali Solmaz

Published in: Acta chirurgica Belgica (2023)

The use of palonosetron significantly reduced the incidence of PONV following laparoscopic sleeve gastrectomy. There was significant improvement in the scores of Functional Living Index-Emesis in patients using palonosetron.

Keyphrases

body weight
chemotherapy induced
end stage renal disease
newly diagnosed
ejection fraction
double blind
patients undergoing
risk factors
prognostic factors
peritoneal dialysis
study protocol
patient reported outcomes
placebo controlled
phase ii